Business
Exalenz provides hepatologists and gastroenterologists with advanced tools for the diagnosis and management of a wide range of conditions in the field of liver health and gastroenterology.
BreathID
The BreathID System is an advanced continuous, automatic, and real-time breath-testing platform that enables the assessment of liver function (hepatic impairment), gastric emptying, and the detection of the presence of the Helicobacter pylori bacteria.
Shares
The company`s stock is traded on the Tel Aviv Stock Exchange (TASE) in Israel. Its ticker symbol is EXEN.
Regulatory
-
USA:
The BreathID System is intended for use in the qualitative detection of H. pylori (It has an approved 510(K) and an approved NDA for the
13
C-urea Tablet and Citrica Powder
)
. Other applications are limited by Federal (of United States) Law to Investigational
Use only.
-
Out of US
:
The BreathID System has a CE mark in the European Union (
for
assessing Helicobacter pylori, Liver Function, and Gastric Emptying Rate
) and and Israel
.